Mark Brosius Sells 464 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 464 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president owned 443 shares in the company, valued at approximately $242,981.07. The trade was a 51.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Mark Brosius also recently made the following trade(s):

• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ:ISRG opened at $554.58 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock’s 50 day moving average is $534.09 and its 200-day moving average is $505.41. The firm has a market capitalization of $198.81 billion, a price-to-earnings ratio of 73.36, a PEG ratio of 5.14 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Tobam raised its stake in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC purchased a new stake in Intuitive Surgical during the second quarter worth about $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical during the second quarter worth about $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. Finally, Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical in the third quarter valued at about $27,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday, October 22nd. Rothschild & Co Redburn raised their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $608.79.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.